162 related articles for article (PubMed ID: 10206173)
1. Mecamylamine-precipitated nicotine-withdrawal aversion in Lewis and Fischer 344 inbred rat strains.
Suzuki T; Ise Y; Maeda J; Misawa M
Eur J Pharmacol; 1999 Mar; 369(2):159-62. PubMed ID: 10206173
[TBL] [Abstract][Full Text] [Related]
2. Mecamylamine-precipitated nicotine-withdrawal aversion in rats.
Suzuki T; Ise Y; Tsuda M; Maeda J; Misawa M
Eur J Pharmacol; 1996 Oct; 314(3):281-4. PubMed ID: 8957247
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron.
Suzuki T; Ise Y; Mori T; Misawa M
Life Sci; 1997; 61(16):PL249-54. PubMed ID: 9353175
[TBL] [Abstract][Full Text] [Related]
4. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
Ise Y; Narita M; Nagase H; Suzuki T
Psychopharmacology (Berl); 2000 Jul; 151(1):49-54. PubMed ID: 10958116
[TBL] [Abstract][Full Text] [Related]
5. Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
Ise Y; Narita M; Nagase H; Suzuki T
Neurosci Lett; 2002 Apr; 323(2):164-6. PubMed ID: 11950518
[TBL] [Abstract][Full Text] [Related]
6. Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats.
Shram MJ; Siu EC; Li Z; Tyndale RF; Lê AD
Psychopharmacology (Berl); 2008 Jun; 198(2):181-90. PubMed ID: 18385986
[TBL] [Abstract][Full Text] [Related]
7. Bupropion attenuates nicotine abstinence syndrome in the rat.
Malin DH; Lake JR; Smith TD; Khambati HN; Meyers-Paal RL; Montellano AL; Jennings RE; Erwin DS; Presley SE; Perales BA
Psychopharmacology (Berl); 2006 Mar; 184(3-4):494-503. PubMed ID: 16163521
[TBL] [Abstract][Full Text] [Related]
8. Reduction in delay discounting due to nicotine and its attenuation by cholinergic antagonists in Lewis and Fischer 344 rats.
Ozga JE; Anderson KG
Psychopharmacology (Berl); 2018 Jan; 235(1):155-168. PubMed ID: 28971227
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
[TBL] [Abstract][Full Text] [Related]
10. Magnitude of open-field thigmotaxis during mecamylamine-precipitated nicotine withdrawal in rats is influenced by mecamylamine dose, duration of nicotine infusion, number of withdrawal episodes, and age.
Harris AC
Pharmacol Biochem Behav; 2021 Jun; 205():173185. PubMed ID: 33831460
[TBL] [Abstract][Full Text] [Related]
11. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.
Malin DH; Lake JR; Carter VA; Cunningham JS; Hebert KM; Conrad DL; Wilson OB
Psychopharmacology (Berl); 1994 Jun; 115(1-2):180-4. PubMed ID: 7862893
[TBL] [Abstract][Full Text] [Related]
12. The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat.
Malin DH; Lake JR; Shenoi M; Upchurch TP; Johnson SC; Schweinle WE; Cadle CD
Psychopharmacology (Berl); 1998 Dec; 140(3):371-7. PubMed ID: 9877017
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in the reward deficit and somatic signs associated with precipitated nicotine withdrawal in rats.
Tan S; Xue S; Behnood-Rod A; Chellian R; Wilson R; Knight P; Panunzio S; Lyons H; Febo M; Bruijnzeel AW
Neuropharmacology; 2019 Dec; 160():107756. PubMed ID: 31487496
[TBL] [Abstract][Full Text] [Related]
14. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
Paterson NE; Markou A
Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336
[TBL] [Abstract][Full Text] [Related]
15. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Hildebrand BE; Nomikos GG; Hertel P; Schilström B; Svensson TH
Brain Res; 1998 Jan; 779(1-2):214-25. PubMed ID: 9473676
[TBL] [Abstract][Full Text] [Related]
16. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
[TBL] [Abstract][Full Text] [Related]
17. Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal.
Göktalay G; Cavun S; Levendusky MC; Hamilton JR; Millington WR
Eur J Pharmacol; 2006 Jan; 530(1-2):95-102. PubMed ID: 16364288
[TBL] [Abstract][Full Text] [Related]
18. Nicotine withdrawal syndrome: behavioural distress and selective up-regulation of the cyclic AMP pathway in the amygdala.
Tzavara ET; Monory K; Hanoune J; Nomikos GG
Eur J Neurosci; 2002 Jul; 16(1):149-53. PubMed ID: 12153540
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area.
Hildebrand BE; Panagis G; Svensson TH; Nomikos GG
Neuropsychopharmacology; 1999 Oct; 21(4):560-74. PubMed ID: 10481840
[TBL] [Abstract][Full Text] [Related]
20. (-)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats.
Horan B; Smith M; Gardner EL; Lepore M; Ashby CR
Synapse; 1997 May; 26(1):93-4. PubMed ID: 9097409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
